DexCom, Inc.
DXCM
$73.18
-$4.66-5.99%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 576.20M | 680.80M | 666.90M | 639.30M | 541.50M |
Total Depreciation and Amortization | 234.40M | 228.90M | 221.80M | 213.40M | 202.50M |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 70.10M | 67.70M | 11.20M | -21.10M | 1.30M |
Change in Net Operating Assets | 108.80M | -155.70M | -8.50M | -29.30M | 3.20M |
Cash from Operations | 989.50M | 821.70M | 891.40M | 802.30M | 748.50M |
Capital Expenditure | -358.80M | -286.70M | -225.90M | -218.80M | -236.60M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 151.30M | 797.80M | 347.20M | -26.90M | -270.60M |
Cash from Investing | -207.50M | 511.10M | 121.30M | -245.70M | -507.20M |
Total Debt Issued | -- | 0.00 | 0.00 | 1.23B | 1.23B |
Total Debt Repaid | -- | -136.80M | -787.30M | -787.30M | -787.30M |
Issuance of Common Stock | 28.20M | 28.20M | 27.70M | 27.70M | 26.60M |
Repurchase of Common Stock | -750.00M | -1.25B | -500.00M | -688.70M | -688.70M |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -13.00M | -6.50M | -6.40M | -107.40M | -99.80M |
Cash from Financing | -734.80M | -1.37B | -1.27B | -325.10M | -318.60M |
Foreign Exchange rate Adjustments | -7.40M | 9.90M | -2.20M | -3.40M | 1.50M |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 39.80M | -22.40M | -255.50M | 228.10M | -75.80M |